International Journal of Surgery Case Reports,
Journal Year:
2021,
Volume and Issue:
86, P. 106307 - 106307
Published: Aug. 11, 2021
CoV-2
infection
generates
a
pro-inflammatory
state,
which
conditions
the
formation
of
thrombi
that
can
affect
any
system.
Multi-organ
dysfunction
is
cause
death,
mesenteric
ischemia
in
COVID
2019
patients
reported
1.9-4%.We
present
case
73-year-old
male
patient
who
started
with
severe
SARS-CoV-2
and
arterial-type
intestinal
ischemia,
necrosis
3
m
small
intestine,
based
on
SCARE
2020
guide.Complications
secondary
to
thrombosis
are
as
follows;
myocardial
infarction
1.1%,
ischemic
cerebral
events,
2.5-3.7%,
microvascular
including
less
than
1%
cases.
In
postoperative
mortality
23.8%
especially
during
first
30
days.Intestinal
increases
mortality.
Biomedicines,
Journal Year:
2021,
Volume and Issue:
9(8), P. 957 - 957
Published: Aug. 4, 2021
Background:
Endothelial
dysfunction
has
a
key
role
in
the
pathogenesis
of
coronavirus
disease
2019
(COVID-19)
and
its
disabling
complications.
We
designed
case-control
study
to
assess
alterations
endothelium-dependent
flow-mediated
dilation
(FMD)
among
convalescent
COVID-19
patients.
Methods:
patients
referred
Pulmonary
Rehabilitation
Unit
within
2
months
from
swab
test
negativization
were
consecutively
evaluated
for
inclusion
compared
controls
matched
age,
gender,
cardiovascular
risk
factors.
Results:
A
total
133
(81.2%
males,
mean
age
61.6
years)
(80.5%
60.4
included.
significantly
lower
FMD
was
documented
as
(3.2%
±
2.6
vs.
6.4%
4.1
p
<
0.001),
confirmed
when
stratifying
population
according
major
clinical
variables.
Among
cases,
females
exhibited
higher
values
males
(6.1%
2.9
2.5%
1.9,
0.001).
Thus,
no
significant
difference
observed
between
cases
subgroup
analysis
on
5.3%
3.4,
=
0.362).
patients,
showed
direct
correlation
with
arterial
oxygen
tension
(rho
0.247,
0.004),
forced
expiratory
volume
1
s
0.436,
vital
capacity
0.406,
diffusing
carbon
monoxide
0.280,
0.008).
Overall,
after
adjusting
confounders,
recent
independent
predictor
(β
−0.427,
Conclusions:
Post-acute
syndrome
is
associated
persistent
sex-biased
endothelial
dysfunction,
directly
correlated
severity
pulmonary
impairment.
Forensic Science Medicine and Pathology,
Journal Year:
2021,
Volume and Issue:
18(1), P. 4 - 19
Published: Aug. 31, 2021
This
study
involves
the
histological
analysis
of
samples
taken
during
autopsies
in
cases
COVID-19
related
death
to
evaluate
inflammatory
cytokine
response
and
tissue
localization
virus
various
organs.
In
all
selected
cases,
SARS-CoV-2
RT-PCR
on
swabs
collected
from
upper
(nasopharynx
oropharynx)
and/or
lower
respiratory
(trachea
primary
bronchi)
tracts
were
positive.
Tissue
was
detected
using
antibodies
against
nucleoprotein
spike
protein.
Overall,
we
tested
hypothesis
that
overexpression
proinflammatory
cytokines
plays
an
important
role
development
COVID-19-associated
pneumonia
by
estimating
expression
multiple
(IL-1β,
IL-6,
IL-10,
IL-15,
TNF-α,
MCP-1),
cells
(CD4,
CD8,
CD20,
CD45),
fibrinogen.
Immunohistochemical
staining
showed
endothelial
expressed
IL-1β
lung
obtained
group
(p
<
0.001).
Similarly,
alveolar
capillary
strong
diffuse
immunoreactivity
for
IL-6
IL-15
TNF-α
a
higher
than
control
CD8
+
T
where
more
numerous
Current
evidence
suggests
storm
is
major
cause
acute
distress
syndrome
(ARDS)
organ
failure
consistently
linked
with
fatal
outcomes.
World Journal of Virology,
Journal Year:
2023,
Volume and Issue:
12(2), P. 68 - 90
Published: March 21, 2023
The
intestinal
lumen
harbors
a
diverse
consortium
of
microorganisms
that
participate
in
reciprocal
crosstalk
with
immune
cells
and
epithelial
endothelial
cells,
forming
multi-layered
barrier
enables
the
efficient
absorption
nutrients
without
an
excessive
influx
pathogens.
Despite
being
lung-centered
disease,
severe
coronavirus
disease
2019
(COVID-19)
affects
multiple
systems,
including
gastrointestinal
tract
pertinent
gut
function.
Severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
can
inflict
either
direct
cytopathic
injury
to
or
indirect
immune-mediated
damage.
Alternatively,
SARS-CoV-2
undermines
structural
integrity
by
modifying
expression
tight
junction
proteins.
In
addition,
induces
profound
alterations
microflora
at
phylogenetic
metabolomic
levels
(dysbiosis)
are
accompanied
disruption
local
responses.
ensuing
dysregulation
gut-lung
axis
impairs
ability
system
elicit
robust
timely
responses
restrict
viral
infection.
vasculature
is
vulnerable
SARS-CoV-2-induced
injury,
which
simultaneously
triggers
activation
innate
coagulation
condition
referred
as
"immunothrombosis"
drives
thrombotic
complications.
Finally,
increased
permeability
allows
aberrant
dissemination
bacteria,
fungi,
endotoxin
into
systemic
circulation
contributes,
certain
degree,
over-exuberant
hyper-inflammation
dictate
form
COVID-19.
this
review,
we
aim
elucidate
SARS-CoV-2-mediated
effects
on
homeostasis
their
implications
progression
disease.
Cells,
Journal Year:
2022,
Volume and Issue:
11(12), P. 1972 - 1972
Published: June 19, 2022
COVID-19
is
a
highly
infectious
respiratory
disease
caused
by
new
coronavirus
known
as
SARS-CoV-2.
characterized
progressive
failure
resulting
from
diffuse
alveolar
damage,
inflammatory
infiltrates,
endotheliitis,
and
pulmonary
systemic
coagulopathy
forming
obstructive
microthrombi
with
multi-organ
dysfunction,
indicating
that
endothelial
cells
(ECs)
play
central
role
in
the
pathogenesis
of
COVID-19.
The
glycocalyx
defined
complex
gel-like
layer
glycosylated
lipid–protein
mixtures,
which
surrounds
all
living
acts
buffer
between
cell
extracellular
matrix.
(EGL)
plays
an
important
vascular
homeostasis
via
regulating
permeability,
adhesion,
mechanosensing
for
hemodynamic
shear
stresses,
antithrombotic
anti-inflammatory
functions.
Here,
we
review
findings
described
EGL
damage
ARDS,
coagulopathy,
multisystem
associated
Mechanistically,
mediators,
reactive
oxygen
species
(ROS),
matrix
metalloproteases
(MMPs),
fragments,
viral
proteins
may
contribute
to
In
addition,
potential
therapeutic
strategies
targeting
treatment
severe
are
summarized
discussed.
Frontiers in Cardiovascular Medicine,
Journal Year:
2022,
Volume and Issue:
8
Published: Feb. 15, 2022
This
study
investigated
the
incidence,
disease
course,
risk
factors,
and
mortality
in
COVID-19
patients
who
developed
both
acute
kidney
injury
(AKI)
cardiac
(ACI),
compared
to
those
with
AKI
only,
ACI
no
(NI).This
retrospective
consisted
of
hospitalized
at
Montefiore
Health
System
Bronx,
New
York
between
March
11,
2020
January
29,
2021.
Demographics,
comorbidities,
vitals,
laboratory
tests
were
collected
during
hospitalization.
Predictive
models
used
predict
AKI,
ACI,
AKI-ACI
onset.
Longitudinal
analyzed
time-lock
discharge
alive
or
death.Of
5,896
patients,
44,
19,
9,
28%
had
NI,
AKI-ACI,
respectively.
Most
presented
very
early
(within
a
day
two)
hospitalization
contrast
(p
<
0.05).
Patients
combined
significantly
older,
more
often
men
higher
levels
cardiac,
kidney,
liver,
inflammatory,
immunological
markers
NI
groups.
The
adjusted
hospital-mortality
odds
ratios
17.1
[95%
CI
=
13.6-21.7,
p
0.001],
7.2
5.4-9.6,
4.7
3.7-6.1,
0.001]
for
respectively,
relative
NI.
A
predictive
model
onset
using
top
predictors
yielded
97%
accuracy.
data
predicted
up
5
days
prior
outcome,
an
area-under-the-curve,
ranging
from
0.68
0.89.COVID-19
markedly
worse
outcomes
only
Common
variables
accurately
AKI-ACI.
ability
identify
could
lead
earlier
intervention
improvement
clinical
outcomes.
Scientific Reports,
Journal Year:
2021,
Volume and Issue:
11(1)
Published: Sept. 29, 2021
Coronavirus
disease
2019
(COVID-19)
is
an
infectious
caused
by
SARS-CoV-2
primarily
affecting
the
respiratory
system
which
can
damage
vessels
walls
virtually
in
any
body
district.
Changes
retinal
are
a
good
marker
for
systemic
vascular
alterations.
This
study
investigated
during
acute
phase
of
COVID-19
and
after
patients
recovery.
Fifty-nine
eyes
from
32
80
53
unexposed
subjects
were
included.
Mean
arteries
diameter
(MAD)
mean
veins
(MVD)
assessed
through
semi-automatic
analysis
on
fundus
color
photos
at
baseline
6
months
later
to
virus.
At
MAD
MVD
significantly
higher
compared
(p
<
0.0001).
Both
decreased
follow-up
(from
97.5
±
10.9
92.2
11.4
µm,
p
0.0001
133.1
19.3
124.6
16.1
0.0001,
respectively).
Despite
this
reduction
remained
severe
subjects.
Transient
dilation
could
serve
biomarker
inflammation
while
long-lasting
alterations
seen
likely
reflect
irreversible
structural
should
be
further
their
possible
effects
tissues
perfusion
function.
EBioMedicine,
Journal Year:
2022,
Volume and Issue:
78, P. 103982 - 103982
Published: April 1, 2022
Endothelial
cell
(EC)
activation,
endotheliitis,
vascular
permeability,
and
thrombosis
have
been
observed
in
patients
with
severe
coronavirus
disease
2019
(COVID-19),
indicating
that
the
vasculature
is
affected
during
acute
stages
of
SARS-CoV-2
infection.
It
remains
unknown
whether
circulating
markers
are
sufficient
to
predict
clinical
outcomes,
unique
COVID-19,
if
permeability
can
be
therapeutically
targeted.Prospectively
evaluating
prevalence
inflammatory,
cardiac,
EC
activation
as
well
developing
a
microRNA
atlas
241
unvaccinated
suspected
infection
allowed
for
prognostic
value
assessment
using
Random
Forest
model
machine
learning
approach.
Subsequent
ex
vivo
experiments
assessed
responses
patient
plasma
were
used
uncover
modulated
gene
regulatory
networks
from
which
rational
therapeutic
design
was
inferred.Multiple
inflammatory
biomarkers
associated
mortality
COVID-19
severity-matched
SARS-CoV-2-negative
patients,
while
dysregulation
specific
microRNAs
at
presentation
poor
COVID-19-related
outcomes
revealed
disease-relevant
pathways.
Integrating
datasets
approach
further
enhanced
risk
prediction
in-hospital
mortality.
Exposure
ECs
resulted
severity-specific
expression
barrier
dysfunction,
ameliorated
angiopoietin-1
mimetic
or
recombinant
Slit2-N.Integration
multi-omics
data
identified
stabilizing
therapies
should
explored
treatment
endothelial
dysfunction
other
diseases
where
has
central
role
pathogenesis.This
work
directly
supported
by
grant
funding
Ted
Rogers
Center
Heart
Research,
Toronto,
Ontario,
Canada
Peter
Munk
Cardiac
Center,
Canada.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 204 - 204
Published: Jan. 17, 2023
Since
the
spread
of
deadly
virus
SARS-CoV-2
in
late
2019,
researchers
have
restlessly
sought
to
unravel
how
enters
host
cells.
Some
proteins
on
each
side
interaction
between
and
cells
are
involved
as
major
contributors
this
process:
(1)
nano-machine
spike
protein
behalf
virus,
(2)
angiotensin
converting
enzyme
II,
mono-carboxypeptidase
key
component
renin
system
cell,
(3)
some
proteases
exploited
by
SARS-CoV-2.
In
review,
complex
process
entrance
into
with
contribution
well
sequential
conformational
changes
tending
increase
probability
complexification
latter
receptor
cells,
discussed.
Moreover,
release
catalytic
ectodomain
II
its
soluble
form
extracellular
space
positive
or
negative
impact
infectivity
considered.
Indian Journal of Orthopaedics,
Journal Year:
2021,
Volume and Issue:
56(2), P. 226 - 236
Published: Oct. 26, 2021
A
combination
of
immune-mediated
vascular
damage
and
routine
use
systemic
corticosteroid
(CS)
therapy
in
COVID-19
may
significantly
increase
the
risk
burden
osteonecrosis
(ON)
after
COVID-19.
This
narrative
review
explores
pathogenesis,
factors,
possible
preventive
early
treatment
measures
for
ON
For
this
review,
an
extensive
literature
search
was
performed
using
PubMed,
Medline,
Science
Direct
databases
from
January
2000
to
August
2021
relevant
articles
on
etiopathogenesis,
epidemiology,
clinical
manifestations,
severe
acute
respiratory
syndrome
coronavirus
(SARS-CoV)
infection
steroid-induced
(SION).
Pathogenesis
COVID-19,
utility
corticosteroids
pathogenesis
SION
vis-a-vis
SARS-CoV
infection,
associated
diagnosis
following
CS
were
discussed.
Preliminary
data
similar
trends
SARS
2003
epidemic
indicate
that
"angiocentric"
SARS-CoV-2
with
high-dose
patients.
Risk
stratification
based
intake
during
can
help
identify
subjects
at
moderate
high-risk
where
follow-up
plans
be
initiated.